{
    "2018-01-03": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Can Merck Regain its Mojo in 2018 After an Unimpressive '17?",
                "features": {
                    "keywords": [
                        "Merck",
                        "Mojo",
                        "Unimpressive"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "5 Reasons to Invest in Novo Nordisk (NVO) Stock Right Now",
                "features": {
                    "keywords": [
                        "Invest",
                        "Novo Nordisk",
                        "Stock",
                        "Reasons"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}